Alphabet Forecast, price target & analysts
Alphabet Target price 2026 - Analyst rating & recommendation
Alphabet Classifications & Recommendation:
Alphabet Price Target
| Target Price | $331.50 |
| Price | $317.32 |
| Potential | 4.47% |
| Number of Estimates | 63 |
| 63 Analysts have issued a price target Alphabet 2027 . The average Alphabet target price is $331.50. This is 4.47% higher than the current stock price. The highest price target is $420.00 32.36% , the lowest is $186.85 41.12% . | |
| A rating was issued by 73 analysts: 63 Analysts recommend Alphabet to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Alphabet stock has an average upside potential 2027 of 4.47% . Most analysts recommend the Alphabet stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
69 Analysts have issued a sales forecast Alphabet 2025 . The average Alphabet sales estimate is $411b . This is 6.55% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $425b 10.36% , the lowest is $329b 14.74% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $350b | 13.87% |
|---|---|---|
| 2025 | $411b | 17.34% |
| 2026 | $466b | 13.40% |
| 2027 | $523b | 12.22% |
| 2028 | $584b | 11.73% |
| 2029 | $650b | 11.23% |
| 2030 | $723b | 11.23% |
| 2031 | $836b | 15.71% |
| 2032 | $865b | 3.42% |
56 Analysts have issued an Alphabet EBITDA forecast 2025. The average Alphabet EBITDA estimate is $181b . This is 26.33% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $190b 32.82% , the lowest is $145b 1.13% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $130b | 29.32% |
|---|---|---|
| 2025 | $181b | 39.82% |
| 2026 | $220b | 21.22% |
| 2027 | $258b | 17.73% |
| 2028 | $294b | 13.77% |
| 2029 | $343b | 16.62% |
| 2030 | $404b | 17.87% |
| 2031 | $480b | 18.69% |
| 2032 | $478b | 0.32% |
EBITDA Margin
| 2024 | 37.01% | 13.57% |
|---|---|---|
| 2025 | 44.10% | 19.16% |
| 2026 | 47.14% | 6.89% |
| 2027 | 49.45% | 4.90% |
| 2028 | 50.35% | 1.82% |
| 2029 | 52.79% | 4.85% |
| 2030 | 55.95% | 5.99% |
| 2031 | 57.38% | 2.56% |
| 2032 | 55.31% | 3.61% |
70 Alphabet Analysts have issued a net profit forecast 2025. The average Alphabet net profit estimate is $132b . This is 5.93% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $140b 12.67% , the lowest is $115b 7.60% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $100b | 35.67% |
|---|---|---|
| 2025 | $132b | 31.47% |
| 2026 | $139b | 5.53% |
| 2027 | $160b | 15.23% |
| 2028 | $181b | 12.97% |
| 2029 | $214b | 18.53% |
| 2030 | $246b | 14.66% |
| 2031 | $318b | 29.20% |
Net Margin
| 2024 | 28.60% | 19.15% |
|---|---|---|
| 2025 | 32.05% | 12.05% |
| 2026 | 29.82% | 6.96% |
| 2027 | 30.62% | 2.68% |
| 2028 | 30.96% | 1.11% |
| 2029 | 32.99% | 6.56% |
| 2030 | 34.01% | 3.09% |
| 2031 | 37.98% | 11.67% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
70 Analysts have issued a Alphabet forecast for earnings per share. The average Alphabet EPS is $10.90 . This is 7.07% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.59 13.85% , the lowest is $9.51 6.58% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $8.04 | 37.67% |
|---|---|---|
| 2025 | $10.90 | 35.57% |
| 2026 | $11.50 | 5.50% |
| 2027 | $13.25 | 15.22% |
| 2028 | $14.97 | 12.98% |
| 2029 | $17.75 | 18.57% |
| 2030 | $20.35 | 14.65% |
| 2031 | $26.29 | 29.19% |
P/E ratio
| Current | 31.17 | 22.18% |
|---|---|---|
| 2025 | 29.12 | 6.58% |
| 2026 | 27.59 | 5.25% |
| 2027 | 23.94 | 13.23% |
| 2028 | 21.19 | 11.49% |
| 2029 | 17.88 | 15.62% |
| 2030 | 15.59 | 12.81% |
| 2031 | 12.07 | 22.58% |
Based on analysts' sales estimates for 2025, the Alphabet stock is valued at an EV/Sales of 9.11 and an P/S ratio of 9.30 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 9.71 | 49.61% |
|---|---|---|
| 2025 | 9.11 | 6.13% |
| 2026 | 8.04 | 11.82% |
| 2027 | 7.16 | 10.89% |
| 2028 | 6.41 | 10.50% |
| 2029 | 5.76 | 10.10% |
| 2030 | 5.18 | 10.09% |
| 2031 | 4.48 | 13.58% |
| 2032 | 4.33 | 3.31% |
P/S ratio
| Current | 9.91 | 47.30% |
|---|---|---|
| 2025 | 9.30 | 6.15% |
| 2026 | 8.20 | 11.82% |
| 2027 | 7.31 | 10.89% |
| 2028 | 6.54 | 10.50% |
| 2029 | 5.88 | 10.10% |
| 2030 | 5.29 | 10.09% |
| 2031 | 4.57 | 13.58% |
| 2032 | 4.42 | 3.30% |
Current Alphabet Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citizens |
Market Outperform
➜
Market Outperform
|
Unchanged | Dec 31 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Dec 22 2025 |
| Wedbush |
Outperform
➜
Outperform
|
Unchanged | Dec 19 2025 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Dec 16 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Dec 12 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Dec 11 2025 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Dec 05 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Citizens:
Market Outperform
➜
Market Outperform
|
Dec 31 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Dec 22 2025 |
|
Unchanged
Wedbush:
Outperform
➜
Outperform
|
Dec 19 2025 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Dec 16 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Dec 12 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Dec 11 2025 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Dec 05 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
